Korean Biotech Sentiment Still Shaky But IPO Recovery Seen By Year-End

Investors Eye Upcoming SK Biopharm Float Next Year

 
• By Jung Won Shin
  
Going public
Korean Biotech IPOs Seen Picking Up • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia